Search

Search Results

• Works not available on the market and orphan works in French Act 2012-287 of 1 March 2012

  Isabel Espín Alba (Author)

  206-225

  2013-06-01

• The extension of the validity period of patents as one of the causes of the judicialization of medicines in Brazil

  Rafaella Dias Gonçalves (Author)

  240-276

  2019-02-01

• The Tension Between “Brand-Name” Drugs And “Generics”: The Pharmaceutical Industry’s Temporary Monopoly And The Public Domain – The Legal Regime For Invention Patents

  Querino Mallmann (Author)

  e20261501005

  2026-08-20

• On novelty in industrial designs

  Denis Borges Barbosa (Author)

  145-184

  2019-12-01

• On novelty in industrial designs

  Denis Borges Barbosa (Author)

  41-81

  2013-06-01

• What is the minimum distance between pharmaceutical trademarks of different origins?

  Denis Borges Barbosa (Author)

  426-457

  2014-02-01

• Extension of the validity period of pharmaceutical patents from the perspective of Brazilian constitutional law

  Rafaella Dias Gonçalves (Author)

  46-81

  2018-10-01

• Legal and philosophical grounds on the origin and ownership of the first patents of invention

  Querino Mallmann (Author)

  301-307

  2014-06-01

• Brazil according to Monsanto: an eternal déjà vu in the mould of Marie-Monique Robin's documentary

  Charlene de Ávila Plaza (Author)

  2015-07-01

• Monsanto's expectation of rights in Brazil over the patent applications for the “technology” Intacta RR2 PRO: where does the innovation actually lie?

  Charlene de Ávila Plaza (Author)

  85-134

  2015-02-01

• Two studies on the legal aspects of the patenting of Roundup Ready technology in Brazil: the issue of transgenic soybean

  Denis Borges Barbosa (Author)

  330-468

  2014-10-01

• Two studies on the legal aspects of the patenting of Roundup Ready technology in Brazil: the issue of transgenic soybean

  Denis Borges Barbosa (Author)

  356-494

  2019-12-01